Correlation Between ReShape Lifesciences and Nyxoah

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ReShape Lifesciences and Nyxoah at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ReShape Lifesciences and Nyxoah into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ReShape Lifesciences and Nyxoah, you can compare the effects of market volatilities on ReShape Lifesciences and Nyxoah and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ReShape Lifesciences with a short position of Nyxoah. Check out your portfolio center. Please also check ongoing floating volatility patterns of ReShape Lifesciences and Nyxoah.

Diversification Opportunities for ReShape Lifesciences and Nyxoah

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between ReShape and Nyxoah is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding ReShape Lifesciences and Nyxoah in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nyxoah and ReShape Lifesciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ReShape Lifesciences are associated (or correlated) with Nyxoah. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nyxoah has no effect on the direction of ReShape Lifesciences i.e., ReShape Lifesciences and Nyxoah go up and down completely randomly.

Pair Corralation between ReShape Lifesciences and Nyxoah

Given the investment horizon of 90 days ReShape Lifesciences is expected to under-perform the Nyxoah. In addition to that, ReShape Lifesciences is 9.26 times more volatile than Nyxoah. It trades about -0.31 of its total potential returns per unit of risk. Nyxoah is currently generating about -0.23 per unit of volatility. If you would invest  1,083  in Nyxoah on November 28, 2024 and sell it today you would lose (83.00) from holding Nyxoah or give up 7.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.45%
ValuesDaily Returns

ReShape Lifesciences  vs.  Nyxoah

 Performance 
       Timeline  
ReShape Lifesciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ReShape Lifesciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Nyxoah 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Nyxoah are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain basic indicators, Nyxoah demonstrated solid returns over the last few months and may actually be approaching a breakup point.

ReShape Lifesciences and Nyxoah Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ReShape Lifesciences and Nyxoah

The main advantage of trading using opposite ReShape Lifesciences and Nyxoah positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ReShape Lifesciences position performs unexpectedly, Nyxoah can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nyxoah will offset losses from the drop in Nyxoah's long position.
The idea behind ReShape Lifesciences and Nyxoah pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency